#AFCON: Arsenal’s Aubameyang Misses Gabon Vs Ghana Over Heart Issues

Arsenal forward Pierre-Emerick Aubameyang is hoping to play for Gabon against Ghana in the Africa Cup of Nations on Friday night after recovering from Covid-19.

Aubameyang – who has been frozen out at Arsenal since being stripped of the captaincy last month in the aftermath of a disciplinary breach – tested positive for the virus after arriving in Cameroon from Dubai for the tournament earlier this month.

The 32-year-old was duly forced to isolate and he missed Gabon’s opening game of AFCON against Comoros on Monday.

Gabon won 1-0 in his absence thanks to Aaron Boupendzas’ goal and now Aubameyang is hoping to return to action for Friday’s Group C meeting with Ghana, which will see him come up against his Arsenal team-mate Thomas Partey.

Aubameyang trained on Wednesday as normal, while former Fulham and Southampton midfielder Mario Lemina was also back in action.

Gabon, however, have been hit by more Covid cases in their camp and will be without more players for the clash with Ghana – who lost their opening game to Morocco on Monday.

The Gabonese federation announced that the star striker, Axel Meye and Nice’s Mario Lemina will also be sidelined from today’s game at the Ahmadou Ahidjo Stadium.

All three were diagnosed with coronavirus recently and latest medical examinations showed they are dealing with minor heart problems as a result of the virus.

Thus, the Confederation of African Football [CAF] wasn’t willing to take any risks.

The Gabonese Federation tweeted: “According to the CAF medical commission, the players Pierre Emerick Aubameyang, Axel Meye and Mario Lemina, just out of Covid, cannot take part in this match.

“The examinations would show cardiac lesions. CAF did not want to take any risks.”

Aubameyang tested positive for COVID-19 on his arrival to the Copa Africa in Cameroon last week.


How would you rate this website's look and feel?

View Results

Loading ... Loading ...

Subscribe to Our VIP Newsletter


Please enter your comment!
Please enter your name here